Press releases

Pharmaleads announces the opening of french sites in its international Phase IIa clinical study of PL37

ANSM (French National Agency for Medicines and Health Products Safety) authorizes the extension of the clinical trial for pain in diabetic neuropathy   Paris, September 28, 2015 – Pharmaleads, the biotech company developing its proprietary Dual Enkephalinase Inhibitors (DENKIs) for the treatment of severe pain, announces today the opening of the first French investigative sites in […] Read full post »

Diabetes trial in UK

Pennine Acute Trust screens the first UK participant to a diabetes trial RESEARCH nurses at The Pennine Acute Hospitals NHS Trust have screened the first participant in the UK to a diabetes trial. The team of specialist nurses identified the first patient who was seen at The Royal Oldham Hospital. The Pennine Acute Trust is […] Read full post »

Dr. Pierre-André Wicker joins Pharmaleads’ Board of Directors

A prominent specialist in drug development, he will accompany Pharmaleads through the next clinical development stages of PL37, the Company’s first molecule aimed at treating neuropathic pain Paris, July the 2nd 2015 – Pharmaleads, a company specialising in the discovery and early-stage development of small molecule inhibitors of metalloproteases for the treatment of severe pain, […] Read full post »

Older posts

Discover our publications
Press & media coverage
Contact & find us

Pharmaleads SA
11, rue Watt
75013 Paris

Tel: +33 (0)1 44 06 70 00
Fax: +33 (0)1 44 06 60 99
info@pharmaleads.com

Get the access map